Purpose: Recently discovered Anabaena variabilis phenylalanine ammonia lyase (AvPAL) proved to be a good candidate for enzyme replacement therapy of phenylketonuria. Outstanding stability properties of a mutant version of this enzyme, produced already in our laboratory, have led us to the idea of culture conditions optimization for soluble expression of this therapeutically valuable enzyme in E. coli.

Methods: In the present study, the gene encoding mutant version of AvPAL was cloned into the pET28a expression vector. Different concentrations of IPTG, induction period, growth temperature, shaking speed, as well as different types of culture media were examined with respect to the amount of recombinant protein produced and specific activity of the enzyme.

Results: Based upon our findings, maximum amount of active mutant enzyme was attained by addition of 0.5 mM IPTG at 150 rpm to the TB culture media. The yield of active enzyme at cluture tempreature of 25 °C and induction period of 18 hour was the highest.

Conclusion: The results of this study indicated that the yield of mutant AvPAL production in E. coli can be affected mainly by culture temperature and inducer concentration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992962PMC
http://dx.doi.org/10.5681/apb.2014.038DOI Listing

Publication Analysis

Top Keywords

anabaena variabilis
8
variabilis phenylalanine
8
phenylalanine ammonia
8
ammonia lyase
8
mutant version
8
induction period
8
culture media
8
mutant
5
enzyme
5
optimized condition
4

Similar Publications

Hexavalent chromium (Cr (VI)) is a heavy metal that is distributed globally and poses a significant threat to the environment through various mechanisms. It can react with soil and water, leading to severe environmental damage. In this study, the toxicity of Cr (VI) was investigated by analyzing two major cyanobacteria species, Nostoc commune and Anabaena variabilis, commonly found in soil along with their consortia.

View Article and Find Full Text PDF
Article Synopsis
  • - Phenylketonuria (PKU) is a genetic disorder that leads to dangerous levels of phenylalanine in the blood due to a deficiency in the enzyme phenylalanine hydroxylase, requiring ongoing treatment to maintain safe levels.
  • - Pegvaliase is an approved enzyme-substitution therapy for patients with uncontrolled PKU, showing significant reductions in blood phenylalanine levels in clinical trials, although individual responses to treatment and required doses can vary.
  • - In a study with 261 adults on pegvaliase treatment for an average of 36.6 months, many participants achieved clinically significant reductions in blood phenylalanine levels, and long-term safety data indicated common side effects like joint pain and injection
View Article and Find Full Text PDF

The cyanoremediation technique for heavy metal (HM) removal from wastewater using live cyanobacteria is promising to reduce the pollution risk both for the environment and human health. In this study, two widely recognized freshwater cyanobacteria, and sp., were used to explore their efficacy in HM (As(v), Cd(ii), Cr(vi), Pb(ii)) removal.

View Article and Find Full Text PDF

Strategies to enhance biohydrogen production from microalgae: A comprehensive review.

J Environ Manage

April 2024

Botany Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt. Electronic address:

Microalgae represent a promising renewable feedstock for the sustainable production of biohydrogen. Their high growth rates and ability to fix carbon utilizing just sunlight, water, and nutrients make them well-suited for this application. Recent advancements have focused on improving microalgal hydrogen yields and cultivation methods.

View Article and Find Full Text PDF

Roles of the N-terminal motif in improving the activity and soluble expression of phenylalanine ammonia lyases in Escherichia coli.

Int J Biol Macromol

March 2024

NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China. Electronic address:

Phenylalanine ammonia-lyase (PAL) has various applications in fine chemical manufacturing and the pharmaceutical industry. In particular, PAL derived from Anabaena variabilis (AvPAL) is used as a therapeutic agent to the treat phenylketonuria in clinical settings. In this study, we aligned the amino acid sequences of AvPAL and PAL derived from Nostoc punctiforme (NpPAL) to obtain several mutants with enhanced activity, expression yield, and thermal stability via amino acid substitution and saturation mutagenesis at the N-terminal position.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!